by | Jun 10, 2024 | Publications
Am J Hematol. 2024 Jun 10. doi: 10.1002/ajh.27404. Online ahead of print. NO ABSTRACT PMID:38856192 | DOI:10.1002/ajh.27404
by | Jun 10, 2024 | Publications
Am J Hematol. 2024 Jun 10. doi: 10.1002/ajh.27405. Online ahead of print. NO ABSTRACT PMID:38856232 | DOI:10.1002/ajh.27405
by | Jun 10, 2024 | Publications
Blood Lymphat Cancer. 2024 Jun 4;14:31-48. doi: 10.2147/BLCTT.S461529. eCollection 2024. ABSTRACT BACKGROUND: Multiple myeloma (MM), an incurable plasma cell malignancy. The significance of the relationship between natural killer (NK) cell-related genes and clinical...
by | Jun 10, 2024 | Publications
Front Med (Lausanne). 2024 May 24;11:1372907. doi: 10.3389/fmed.2024.1372907. eCollection 2024. ABSTRACT INTRODUCTION: Multiple Myeloma (MM) is classified as one of the most challenging cancers to diagnose, and the hematological malignancy is associated with prolonged...
by | Jun 10, 2024 | Publications
JBMR Plus. 2024 May 23;8(7):ziae066. doi: 10.1093/jbmrpl/ziae066. eCollection 2024 Jul. ABSTRACT Bone disease associated with multiple myeloma (MM) is characterized by osteolytic lesions and pathological fractures, which remain a therapeutic priority despite new drugs...
by | Jun 10, 2024 | Publications
Transplant Cell Ther. 2024 Jun 7:S2666-6367(24)00438-X. doi: 10.1016/j.jtct.2024.06.001. Online ahead of print. ABSTRACT BACKGROUND: Upfront autologous stem cell transplantation (auto-SCT) remains standard of care for eligible patients with newly-diagnosed multiple...